Leibel SA - Search Results

1

Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy.

Mechalakos JG, Mageras GS, Zelefsky MJ, Lyass O, van Herk M, Kooy HM, Leibel SA, Ling CC. Mechalakos JG, et al. Among authors: leibel sa. Radiother Oncol. 2002 Mar;62(3):261-5. doi: 10.1016/s0167-8140(01)00466-2. Radiother Oncol. 2002. PMID: 12175556

2

Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer.

Padula GD, Zelefsky MJ, Venkatraman ES, Fuks Z, Lee HJ, Natale L, Leibel SA. Padula GD, et al. Among authors: leibel sa. Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):439-43. doi: 10.1016/s0360-3016(01)02604-9. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872290

3

Intensity-modulated radiotherapy.

Leibel SA, Fuks Z, Zelefsky MJ, Wolden SL, Rosenzweig KE, Alektiar KM, Hunt MA, Yorke ED, Hong LX, Amols HI, Burman CM, Jackson A, Mageras GS, LoSasso T, Happersett L, Spirou SV, Chui CS, Ling CC. Leibel SA, et al. Cancer J. 2002 Mar-Apr;8(2):164-76. doi: 10.1097/00130404-200203000-00010. Cancer J. 2002. PMID: 12004802

4

Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer.

Levegrün S, Jackson A, Zelefsky MJ, Venkatraman ES, Skwarchuk MW, Schlegel W, Fuks Z, Leibel SA, Ling CC. Levegrün S, et al. Among authors: leibel sa. Radiother Oncol. 2002 Apr;63(1):11-26. doi: 10.1016/s0167-8140(02)00062-2. Radiother Oncol. 2002. PMID: 12065099

5

Intensity-modulated radiation therapy for prostate cancer.

Zelefsky MJ, Fuks Z, Leibel SA. Zelefsky MJ, et al. Among authors: leibel sa. Semin Radiat Oncol. 2002 Jul;12(3):229-37. doi: 10.1053/srao.2002.00000. Semin Radiat Oncol. 2002. PMID: 12118388 Review.

6

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.

Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, Amols H, Venkatraman ES, Leibel SA. Zelefsky MJ, et al. Among authors: leibel sa. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1111-6. doi: 10.1016/s0360-3016(02)02857-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12128109

7

Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.

Katz MS, Zelefsky MJ, Venkatraman ES, Fuks Z, Hummer A, Leibel SA. Katz MS, et al. Among authors: leibel sa. J Clin Oncol. 2003 Feb 1;21(3):483-9. doi: 10.1200/JCO.2003.12.043. J Clin Oncol. 2003. PMID: 12560439 Clinical Trial.

8

A study of the effects of internal organ motion on dose escalation in conformal prostate treatments.

Happersett L, Mageras GS, Zelefsky MJ, Burman CM, Leibel SA, Chui C, Fuks Z, Bull S, Ling CC, Kutcher GJ. Happersett L, et al. Among authors: leibel sa. Radiother Oncol. 2003 Mar;66(3):263-70. doi: 10.1016/s0167-8140(03)00039-2. Radiother Oncol. 2003. PMID: 12742265

9

Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer.

Leibel SA, Fuks Z, Zelefsky MJ, Hunt M, Burman CM, Mageras GS, Chui CS, Jackson A, Amols HI, Ling CC. Leibel SA, et al. Semin Oncol. 2003 Oct;30(5):596-615. doi: 10.1016/s0093-7754(03)00354-3. Semin Oncol. 2003. PMID: 14571409 Review.

10

Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.

Kattan MW, Zelefsky MJ, Kupelian PA, Cho D, Scardino PT, Fuks Z, Leibel SA. Kattan MW, et al. Among authors: leibel sa. J Clin Oncol. 2003 Dec 15;21(24):4568-71. doi: 10.1200/JCO.2003.05.046. J Clin Oncol. 2003. PMID: 14673043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters